Analysis of erectile responses to bradykinin in the anesthetized rat
- 1 August 2015
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 309 (3) , H499-H511
Abstract
The kallikrein-kinin system is expressed in the corpus cavernosa, and bradykinin (BK) relaxes isolated corpora cavernosal strips. However, erectile responses to BK in the rat have not been investigated in vivo. In the present study, responses to intracorporal (ic) injections of BK were investigated in the anesthetized rat. BK, in doses of 1–100 μg/kg ic, produced dose-related increases in intracavernosal pressure (ICP) and dose-related deceases in mean arterial pressure (MAP). When decreases in MAP were prevented by intravenous injections of angiotensin II (Ang II), increases in ICP, in response to BK, were enhanced. Increases in ICP, ICP/MAP ratio, and area under the curve and decreases in MAP in response to BK were inhibited by the kinin B2 receptor antagonist HOE-140 and enhanced by the angiotensin-converting enzyme (ACE) inhibitor captopril and by Ang-(1–7). Increases in ICP, in response to BK, were not attenuated by the nitric oxide (NO) synthase inhibitor ( Nω-nitro-l-arginine methyl ester) or the soluble guanylate cyclase inhibitor (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) but were attenuated by the cyclooxygenase inhibitor, sodium meclofenamate. Decreases in MAP were not attenuated by either inhibitor. These data suggest that erectile responses are mediated by kinin B2 receptors and modulated by decreases in MAP. These data indicate that ACE is important in the inactivation of BK and that erectile and hypotensive responses are independent of NO in the penis or the systemic vascular bed. Erectile responses to cavernosal nerve stimulation are not altered by BK or HOE-140, suggesting that BK and B2 receptors do not modulate nerve-mediated erectile responses under physiologic conditions. These data suggest that erectile responses to BK are mediated, in part, by the release of cyclooxygenase products.Keywords
Funding Information
- HHS | National Institutes of Health (NIH) (HL 77421, HL 103974)
This publication has 53 references indexed in Scilit:
- Altered regional blood flow distribution in Mas-deficient miceTherapeutic Advances in Cardiovascular Disease, 2012
- Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erectionProceedings of the National Academy of Sciences, 2012
- Analysis ofl-NAME-dependent and -resistant responses to acetylcholine in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Responses to bradykinin are mediated by NO-independent mechanisms in the rat hindlimb vascular bedPharmacological Research, 2004
- Potentiation of Bradykinin by Angiotensin-(1-7) on Arterioles of Spontaneously Hypertensive Rats Studied In VivoHypertension, 2001
- Angiotensin-(1–7) Is a Modulator of the Human Renin-Angiotensin SystemHypertension, 1999
- Pharmacological characterization of kinin‐induced relaxation of human corpus cavernosumBritish Journal of Urology, 1998
- Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric OxideHypertension, 1997
- INFLUENCE OF HOE 140, A BRADYKININ RECEPTOR ANTAGONIST, IN THE ISOLATED MESENTERIC VASCULAR BED OF THE RATAmerican Journal of Therapeutics, 1996
- Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious RatsHypertension, 1995